Never miss a great news story!
Get instant notifications from Economic Times
AllowNot now


You can switch off notifications anytime using browser settings.
11,910.1553.35
Stock Analysis, IPO, Mutual Funds, Bonds & More

Lotus Eye Hospital and Institute Ltd.

AllNewsAnnouncementRecos

BSE LIVE

Change:

Volume:

Open:

Prv. Close:

Today:

Lotus Eye Hospital and Institute Ltd.

52-Wk:

Lotus Eye Hospital and Institute Ltd.

Bid:

()

Offer:

()

NSE LIVE

Change:

Volume:

Open:

Prv. Close:

Today:

Lotus Eye Hospital and Institute Ltd.

52-Wk:

Lotus Eye Hospital and Institute Ltd.

Bid:

()

Offer:

()

Lotus Eye Hospital and Institute Announcement under Regulation 30 (LODR)-Meeting Updates

| Announcement

CORRIGENDUM TO THE OUTCOME OF THE BOARD MEETING HELD ON 14.11.2019

Lotus Eye Hospital and Institute RESULTS AS ON 30.09.2019

| Announcement

RESULTS AS ON 30.09.2019

Lotus Eye Hospital and Institute RESULTS FOR HALF YEAR ENDED 30TH SEP 2019

| Announcement

RESULTS FOR HALF YEAR ENDED 30TH SEP 2019

Lotus Eye Hospital and Institute Board Meeting Intimation for We Hereby Give Prior Intimation That A Meeting Of The Board Of Directors Of The Company Wil...

| Announcement

Lotus Eye Hospital And Institute Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2019 ,inter alia, to consider and approve Pursuant to regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby give prior intimation that a Meeting of the Board of Directors of the Company will be held on Thursday, the 14th Day of November, 2019 to inter alia consider and approve Un-Audited Financial Results for the Quarter ended/Half year ended 30th September, 2019.

Lotus Eye Hospital and Institute Reg 40 (10) - PCS Certificate For Transfer/Transmission/Transposition

| Announcement

Reg 40 (10) - PCS certificate for transfer/transmission/transposition for the half - year ended 30th September, 2019

Lotus Eye Hospital and Institute Compliance Certificate For The Half Year Ended 30Th Sep, 2019

| Announcement

Compliance certificate for the half year ended 30th Sep, 2019

Lotus Eye Hospital and Institute Statement Of Investor Complaints For The Quarter Ended September 2019

| Announcement

<table border=1><tr bgcolor=#d6d6d6><th class=TTRow-left> No.of Investor complaints pending at the beginning of the quarter </th><th class=TTRow> No.of Investor complaints received during the quarter</th><th class=TTRow> No.of Investor complaints disposed of during the quarter </th><th class=TTRow> No.of Investor complaints unresolved at the end of the quarter </th></tr><tr><td class=TTRow>0</td><td class=TTRow>0</td><td class=TTRow>0</td><td class=TTRow>0</td></tr></table><table border=1><tr><td > <span style=font-weight:bold>Name of the Signatory </span> </td><td> :- </td><td>Aakanksha Parmar</td></tr><tr><td ><span style=font-weight:bold>Designation </span></td><td> :- </td><td>Company Secretary and Compliance Officer</td></tr></table>

Lotus Eye Hospital and Institute Shareholding for the Period Ended September 30, 2019

| Announcement

Lotus Eye Hospital And Institute Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2019. For more details, kindly <a href="http://www.bseindia.com/corporates/shpSecurities.aspx?scripcd=532998&qtrid=103.00">Click here</a>

Lotus Eye Hospital and Institute Closure of Trading Window

| Announcement

CLOSURE OF TRADING WINDOW

Lotus Eye Hospital and Institute Closure of Trading Window

| Announcement

Closure of Trading Window

Lotus Eye Hospital and Institute Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

| Announcement

Lotus Eye Hospital And Institute Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly <a href="https://www.bseindia.com/stock-share-price/meetings/voting-results/532998"> Click here</a>

Lotus Eye Hospital and Institute Shareholder Meeting / Postal Ballot-Scrutinizers Report

| Announcement

Result of 22nd Annual General Meeting

Lotus Eye Hospital and Institute Book Closure For The Purpose Of 22Nd Annual General Meeting

| Announcement

Book closure for the purpose of 22nd Annual General meeting

Lotus Eye Hospital and Institute SHAREHOLDER MEETING ON 24.09.219

| Announcement

22ND ANNUAL GENERAL MEETING TO BE HELD ON 24.09.2019

Lotus Eye Hospital and Institute Reg. 34 (1) Annual Report

| Announcement

Annual Report for f.y. 2018-19

Lotus Eye Hospital and Institute Results - Financial Results 30.06.2019

| Announcement

Results - Financial Results 30.06.2019

Lotus Eye Hospital and Institute Outcome of Board Meeting

| Announcement

Outcome of the Board Meeting on 12.08.2019

Lotus Eye Hospital and Institute Announcement under Regulation 30 (LODR)-Monthly Business Updates

| Announcement

Letter to shareholders by Dr. S.K. Sundaramoorthy, chairman cum Managing Director

Lotus Eye Hospital and Institute Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)

| Announcement

Pursuant to regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that Mr. L. Sriram has resigned from the position of chief financial officer and Key managerial person of the company due to personal reasons with immediate effect from closing hours of Thursday, July 25, 2019.

Lotus Eye Hospital and Institute Shareholding for the Period Ended June 30, 2019

| Announcement

Lotus Eye Hospital And Institute Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2019. For more details, kindly <a href="http://www.bseindia.com/corporates/shpSecurities.aspx?scripcd=532998&qtrid=102.00">Click here</a>

Lotus Eye Hospital and Institute Statement Of Investor Complaints For The Quarter Ended June 2019

| Announcement

<table border=1><tr bgcolor=#d6d6d6><th class=TTRow-left> No.of Investor complaints pending at the beginning of the quarter </th><th class=TTRow> No.of Investor complaints received during the quarter</th><th class=TTRow> No.of Investor complaints disposed of during the quarter </th><th class=TTRow> No.of Investor complaints unresolved at the end of the quarter </th></tr><tr><td class=TTRow>0</td><td class=TTRow>0</td><td class=TTRow>0</td><td class=TTRow>0</td></tr></table><table border=1><tr><td > <span style=font-weight:bold>Name of the Signatory </span> </td><td> :- </td><td>Aakanksha Parmar</td></tr><tr><td ><span style=font-weight:bold>Designation </span></td><td> :- </td><td>Company Secretary and Compliance Officer</td></tr></table>

Lotus Eye Hospital and Institute Closure of Trading Window

| Announcement

Closure of Trading Window

Lotus Eye Hospital and Institute Results As On 31.03.2019

| Announcement

Minor revision for results as on 31.03.2019

Lotus Eye Hospital and Institute Financial Results Clarifications

| Announcement

Financial results clarifications

Lotus Eye Hospital and Institute Reg.24(A)-Annual Secretarial Compliance

| Announcement

<b>Annual Secretarial Compliance Report</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Period for which the report has been issued </td><td>31/03/2019</td></tr> <tr><td>2</td><td>Date of Report</td><td>27/05/2019</td></tr> <tr><td>3</td> <td>Name of the Certifying Firm </td> <td>P. ESWARAMOORTHY AND COMPANY</td></tr> <tr><td>4</td><td> Name of the Certifying Individual </td><td>P. ESWARAMOORTHY</td></tr> <tr><td>5</td><td>Membership Type</td><td>FCS</td></tr> <tr><td>6</td><td> Membership Number </td><td>6510</td></tr> <tr><td>7</td><td> CP No. </td><td>7069</td></tr> <tr><td>8</td><td> Whether any observations/qualification reported by the Secretarial Auditor ? </td><td>Yes</td></tr> </table> <br/><br/>

Lotus Eye Hospital and Institute Announcement under Regulation 30 (LODR)-Dividend Updates

| Announcement

After much deliberation, the management has decided not to declare dividends for the financial year ending 31st March, 2019.

Lotus Eye Hospital and Institute Results - Financial Year Ending 31St March, 2019

| Announcement

Results - Financial year ending 31st March, 2019

Lotus Eye Hospital and Institute Outcome of Board Meeting

| Announcement

Outcome of the Board meeting held on 28/05/2019

Lotus Eye Hospital and Institute Format of Initial Disclosure to be made by an entity identified as a Large Corporate

| Announcement

<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Compay</td><td>Lotus Eye Hospital And Institute Ltd</td></tr> <tr><td>2</td><td>CIN</td><td>L85110TZ1997PLC007783</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr)</td> <td>0.09</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>na</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the framework</td><td>NSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: Aakanksha Parmar <br/> Designation: Company Secretary <br/> EmailId: companysecretary@lotuseye.org</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: L. Sriram <br/> Designation: Chief Financial oFFICER <br/> EmailId: financehead@lotuseye.org</div> </div> <div> <br/> Date: 21/05/2019<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>

Lotus Eye Hospital and Institute Compliances - Reg40(10) - PCS Certificate For Transfer/Transmission/Transposition.

| Announcement

Compliances - Reg40(10) - PCS Certificate for transfer/Transmission/Transposition.

Lotus Eye Hospital and Institute Shareholding for the Period Ended March 31, 2019

| Announcement

Lotus Eye Hospital And Institute Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2019. For more details, kindly <a href="http://www.bseindia.com/corporates/shpSecurities.aspx?scripcd=532998&qtrid=101.00">Click here</a>

Lotus Eye Hospital and Institute Compliance Certificate For The Period Ended 31St March, 2019.

| Announcement

Compliance certificate for the period ended 31st March, 2019.

Lotus Eye Hospital and Institute Compliances-Certificate under Reg. 54 (5) of SEBI (DP) Regulations, 1996

| Announcement

Compliance certificate

Lotus Eye Hospital and Institute Statement Of Investor Complaints For The Quarter Ended March 2019

| Announcement

<table border=1><tr bgcolor=#d6d6d6><th class=TTRow-left> No.of Investor complaints pending at the beginning of the quarter </th><th class=TTRow> No.of Investor complaints received during the quarter</th><th class=TTRow> No.of Investor complaints disposed of during the quarter </th><th class=TTRow> No.of Investor complaints unresolved at the end of the quarter </th></tr><tr><td class=TTRow>0</td><td class=TTRow>0</td><td class=TTRow>0</td><td class=TTRow>0</td></tr></table><table border=1><tr><td > <span style=font-weight:bold>Name of the Signatory </span> </td><td> :- </td><td>Aakanksha Parmar</td></tr><tr><td ><span style=font-weight:bold>Designation </span></td><td> :- </td><td>Company Secretary and Compliance Officer</td></tr></table>

Lotus Eye Hospital and Institute Closure of Trading Window

| Announcement

Closure of Trading window

Lotus Eye Hospital and Institute Outcome of Board Meeting

| Announcement

Outcome of Board Meeting

Lotus Eye Hospital and Institute Results For Quarter Ended 31.12.2018

| Announcement

Results for quarter ended 31.12.2018

Lotus Eye Hospital and Institute Results - Financial Results For Quarter Ended 31St December, 2018

| Announcement

Pursuant to Regulation 33 of SEBI (LODR) Regulations, 2015, please find enclosed herewith the following: Un-audited financial results (standalone) for the quarter ended 31st December, 2018, along with Limited Review Report.

Lotus Eye Hospital and Institute Shareholding for the Period Ended December 31, 2018

| Announcement

Lotus Eye Hospital And Institute Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2018. For more details, kindly <a href="http://www.bseindia.com/corporates/shpSecurities.aspx?scripcd=532998&qtrid=100.00">Click here</a>

Lotus Eye Hospital and Institute Statement Of Investor Complaints For The Quarter Ended December 2018

| Announcement

<table border=1><tr bgcolor=#d6d6d6><th class=TTRow-left> No.of Investor complaints pending at the beginning of the quarter </th><th class=TTRow> No.of Investor complaints received during the quarter</th><th class=TTRow> No.of Investor complaints disposed of during the quarter </th><th class=TTRow> No.of Investor complaints unresolved at the end of the quarter </th></tr><tr><td class=TTRow>0</td><td class=TTRow>0</td><td class=TTRow>0</td><td class=TTRow>0</td></tr></table><table border=1><tr><td > <span style=font-weight:bold>Name of the Signatory </span> </td><td> :- </td><td>Aakanksha Parmar</td></tr><tr><td ><span style=font-weight:bold>Designation </span></td><td> :- </td><td>Company Secretary and Compliance Officer</td></tr></table>

Other useful Links


Follow us on


Download et app


Copyright © 2019 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service